切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2013, Vol. 07 ›› Issue (06) : 496 -500. doi: 10.3877/cma.j.issn.1674-0793.2013.06.019

所属专题: 文献

综述

立体定向放射消融治疗肝胰肿瘤的临床应用进展
王振宇1, 张群1, 文碧秀1   
  1. 1. 510080 广州,中山大学附属第一医院放射治疗科
  • 收稿日期:2013-04-09 出版日期:2013-12-01

Advance and clinical application of stereotactic ablative radiotherapy in liver and pancreatic cacinoma

Zhen-yu WANG1, Qun ZHANG1, Bi-xiu WEN1   

  1. 1. Department of Radiation Oncology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2013-04-09 Published:2013-12-01
引用本文:

王振宇, 张群, 文碧秀. 立体定向放射消融治疗肝胰肿瘤的临床应用进展[J]. 中华普通外科学文献(电子版), 2013, 07(06): 496-500.

Zhen-yu WANG, Qun ZHANG, Bi-xiu WEN. Advance and clinical application of stereotactic ablative radiotherapy in liver and pancreatic cacinoma[J]. Chinese Archives of General Surgery(Electronic Edition), 2013, 07(06): 496-500.

立体定向放射消融(SABR)是一种对肿瘤靶区采用单次或几次大剂量的精确照射,使肿瘤靶区形成放射性毁损,而靶区外正常组织受照剂量很小的治疗手段。目前该技术治疗不能手术的原发性肝细胞癌、早期非小细胞肺癌等取得了较好的疗效,并越来越多地被应用于腹部肿瘤临床。本文就立体定向放射消融在肝胰肿瘤的临床应用及其在放射物理生物学方面的进展做一综述。

Stereotactic ablative radiotherapy (SABR) is a special type of radiation therapy to deliver a high dose of radiation to the extracranial tumor in one or a small number of fractions with a high degree of precision. The tumor target is destroyed by ionizing irradiation while minimizing the exposure of radiation to normal tissues. SABR has been applied to treat patients with medically inoperable primary hepatocellular carcinoma, non-small-cell lung cancer and so on with promising effect. This article has comprehensively reviewed the clinical application of SABR in liver and pancreatic cancer and the progress in radiophysics and radiobiology of SABR.

1
Potters L, Steinberg M, Rose C, et al. American Society for Therapeutic Radiology and Oncology and American College of Radiology practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys, 2004, 60(4): 1026-1032.
2
Galvin JM, Bednarz G. Quality assurance procedures for stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys, 2008, 71(1 Suppl): S122-125.
3
Lo SS, Fakiris AJ, Chang EL, et al. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol, 2010, 7(1): 44-54.
4
Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys, 2010, 37(8): 4078-4101.
5
Timmerman RD, Kavanagh BD. Stereotactic body radiation therapy. Curr Probl Cancer, 2005, 29(3): 120-157.
6
Ibarra RA, Rojas D, Snyder L, et al. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol, 2012, 51(5): 575-583.
7
Goyal K, Einstein D, Yao M, et al. Cyberknife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results. HPB Surg, 2010, 2010. pii: 309780.
8
Dewas S, Bibault J E, Mirabel X, et al. Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy. Radiat Oncol, 2012, 7: 166.
9
Goodman KA, Wiegner EA, Maturen KE, et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys, 2010, 78(2): 486-493.
10
Mendez Romero A, Wunderink W, Hussain SM, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol, 2006, 45(7): 831-837.
11
Cardenes HR, Price TR, Perkins SM, et al. Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma. Clin Transl Oncol, 2010, 12(3): 218-225.
12
吕光明,钟南保,陈忠华, 等. 立体定向放射治疗原发性肝癌的疗效分析. 实用肝脏病杂志, 2009, 12(6): 435-436.
13
张重魁,刘红军,陈标, 等. 立体定向放射治疗原发性肝癌的疗效观察. 实用癌症杂志, 2008, 23(3): 288-290.
14
Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol, 2009, 27(10): 1585-1591.
15
Rusthoven KE, Kavanagh BD, Cardenes H, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol, 2009, 27(10): 1572-1578.
16
张烨,肖建平,李晔雄, 等. 体部立体定向放射治疗肝转移瘤22例临床疗效. 中华放射肿瘤学杂志, 2010, 19(2): 135-138.
17
杨志祥,王阁,王东, 等. 立体定向放射治疗肝转移癌临床疗效观察. 重庆医学, 2007, 36(19): 1953-1954.
18
Salama JK, Kirkpatrick JP, Yin FF. Stereotactic body radiotherapy treatment of extracranial metastases. Nat Rev Clin Oncol, 2012, 9(11): 654-665.
19
Schellenberg D, Goodman KA, Lee F, et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys, 2008, 72(3): 678-686.
20
Schellenberg D, Kim J, Christman-Skieller C, et al. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys, 2011, 81(1): 181-188.
21
Taniguchi CM, Murphy JD, Eclov N, et al. Dosimetric Analysis of Organs at Risk During Expiratory Gating in Stereotactic Body Radiation Therapy for Pancreatic Cancer. Int J Radiat Oncol Biol Phys, 2012,
22
Goyal K, Einstein D, Ibarra RA, et al. Stereotactic body radiation therapy for nonresectable tumors of the pancreas. J Surg Res, 2012, 174(2): 319-325.
23
Mahadevan A, Jain S, Goldstein M, et al. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys, 2010, 78(3): 735-742.
24
高宏,张虹,邵秋菊, 等. 立体定向放射治疗胰腺癌112例疗效观察. 现代肿瘤医学, 2010, 18(1): 112-113.
25
季洪兵,吕光明,钟南保, 等. 立体定向放射治疗胰腺癌的疗效分析. 实用肝脏病杂志, 2010, 13(6): 436-437, 440.
26
吴铁鹰,张峻青,刘永兰, 等. 立体定向放射治疗联合吉西他滨治疗局部晚期胰腺癌疗效分析. 肿瘤研究与临床, 2012, 24(7): 490-492.
27
季洪兵,吕光明. 立体定向放射治疗原发性肝癌伴下腔静脉癌栓的疗效评价. 实用肝脏病杂志, 2011, 14(1): 37-39.
28
季洪兵,吕光明. 内支架置入联合立体定向放疗治疗肝癌致下腔静脉癌栓临床研究. 中华实用诊断与治疗杂志, 2011, 25(6): 602-604.
29
季洪兵,吕光明,钟南保. 胆管引流联合立体定向放疗治疗恶性梗阻性黄疸临床分析. 中华实用诊断与治疗杂志, 2011, 25(4): 393-395.
30
Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol, 2007, 25(8): 947-952.
31
Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys, 2008, 70(3): 847-852.
32
Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol, 2006, 24(30): 4833-4839.
33
Chang EL, Shiu AS, Lii MF, et al. Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases. Int J Radiat Oncol Biol Phys, 2004, 59(5): 1288-1294.
34
Chang EL, Shiu AS, Mendel E, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine, 2007, 7(2): 151-160.
35
Wolbarst AB, Chin LM, Svensson GK. Optimization of radiation therapy: integral-response of a model biological system. Int J Radiat Oncol Biol Phys, 1982, 8(10): 1761-1769.
[1] 江泽莹, 王安婷, 王姣丽, 陈慈, 周秋玲, 黄燕娟, 周芳, 薛琰, 周剑烽, 谭文勇, 杜美芳. 多种植物油组分预防肿瘤放化疗相关毒性反应的效果分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 523-527.
[2] 徐耀博, 吴斌全. 三维可视化技术结合术中超声在可切除肝癌腹腔镜手术的应用[J]. 中华普通外科学文献(电子版), 2022, 16(04): 273-277.
[3] 尚培中, 张润萍, 张伟, 贾国洪, 李晓武, 苗建军, 刘冰. 梗阻性黄疸临床防治新技术单中心应用研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 104-107.
[4] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[5] 董奕琦, 罗耀兵, 刘涛, 张岚, 杨明. 血流拓扑学肝分段与Couinaud肝分段在原发性肝癌术前评估及手术规划中的应用价值[J]. 中华普外科手术学杂志(电子版), 2022, 16(04): 423-426.
[6] 王勤运, 许大彬, 张恩犁, 钱海, 赵之明. 完全脏器转位机器人胰十二指肠切除术一例[J]. 中华腔镜外科杂志(电子版), 2023, 16(01): 52-55.
[7] 李新雄, 张再重, 赵虎, 肖春红, 王烈. 作为胰腺癌生物标志物的外泌体内容物研究进展[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(01): 53-57.
[8] 韩冰, 顾劲扬. 深度学习神经网络在肝癌诊疗中的研究及应用前景[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 480-485.
[9] 赫嵘, 贾哲, 张珂, 李代京, 张萌, 蒋力. 基于PSM分析腹腔镜肝切除联合Hassab术治疗合并门静脉高压症肝癌疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 376-383.
[10] 葛云鹏, 崔红元, 宋京海. 人工智能在原发性肝癌诊断、治疗及预后中的应用[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 367-371.
[11] 曹文玺, 陈箫, 竺来法, 周永平. 尼妥珠单抗联合白蛋白结合型紫杉醇治疗胰腺癌的有效性及安全性分析[J]. 中华临床医师杂志(电子版), 2023, 17(04): 409-413.
[12] 任刚, 沈光凯, 王颖杰. 胰腺癌消融放疗的研究进展[J]. 中华临床医师杂志(电子版), 2022, 16(12): 1276-1279.
[13] 任刚, 沈光凯, 宋佳钊, 李晶, 王勇, 王颖杰. 高剂量少分次放疗对胰腺癌患者免疫功能、营养及体力状态的影响[J]. 中华临床医师杂志(电子版), 2022, 16(09): 876-880.
[14] 黄学卿, 魏楠, 蒋天鹏, 安天志, 王黎洲, 许敏, 周石. 超声引导经远端桡动脉入路行肝癌TACE术的临床研究[J]. 中华介入放射学电子杂志, 2023, 11(03): 251-256.
[15] 陈升鑫, 翟亚奇, 卜保国, 陈德鑫, 吴浪, 方开萱, 刘文静, 李明阳, 令狐恩强. 自身免疫性胰腺炎临床特征分析[J]. 中华胃肠内镜电子杂志, 2023, 10(01): 46-51.
阅读次数
全文


摘要